Tolvaptan Reduces Extracellular Fluid per Amount of Body Fluid Reduction Less Markedly than Conventional Diuretics

OBJECTIVE: Tolvaptan, a vasopressin V2 receptor antagonist, is a water diuretic, removing electrolyte-free water from the kidneys and affecting the water balance between the intracellular and extracellular fluid. We previously reported that tolvaptan efficiently reduced the intracellular fluid volum...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwatani, Hirotsugu, Yamato, Masafumi, Bessho, Saki, Mori, Yuki, Notsu, Shoki, Asahina, Yuta, Koizumi, Shintaro, Kimura, Yoshiki, Shimomura, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492492/
https://www.ncbi.nlm.nih.gov/pubmed/35110480
http://dx.doi.org/10.2169/internalmedicine.8533-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492492/
https://www.ncbi.nlm.nih.gov/pubmed/35110480
http://dx.doi.org/10.2169/internalmedicine.8533-21

Ejemplares similares